tiprankstipranks
MaxCyte (MXCT) (MXCT)
:MXCT
US Market
MXCT
MaxCyte
RESEARCH TOOLSreports

MaxCyte (MXCT) Income Statement

Compare
75 Followers

MaxCyte Income Statement

Last quarter (Q4 2025), MaxCyte's total revenue was $7.30M, a decrease of -16.02% from the same quarter last year. In Q4, MaxCyte's net income was $-9.60M. See MaxCyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 33.03M$ 38.63M$ 41.29M$ 44.26M$ 33.89M
Gross Profit
$ 26.80M$ 31.53M$ 36.55M$ 39.16M$ 30.25M
Operating Expenses
$ 72.48M$ 82.72M$ 84.84M$ 66.52M$ 48.44M
Depreciation and Amortization
$ 5.14M$ 4.79M$ 4.17M$ 2.70M$ 1.42M
EBITDA
$ -40.14M$ -46.41M$ -44.13M$ -24.66M$ -16.61M
Operating Income
$ -43.55M$ -51.20M$ -48.30M$ -27.36M$ -18.19M
Other Income/Expenses
$ -1.08M$ 10.14M$ 10.38M$ 3.79M$ -893.60K
Pretax Income
$ -44.63M$ -41.05M$ -37.92M$ -23.57M$ -19.08M
Net Income
$ -44.63M$ -41.05M$ -37.92M$ -23.57M$ -19.08M
Per Share Metrics
Basic EPS
$ -0.42$ -0.39$ -0.37$ -0.19$ -0.22
Diluted EPS
$ -0.42$ -0.39$ -0.37$ -0.19$ -0.22
Weighted Average Shares Outstanding
 106.43M 104.85M 103.27M 101.70M 90.62M
Weighted Average Shares Outstanding (Diluted)
 106.43M 104.85M 103.27M 101.70M 90.62M
Currency in USD

MaxCyte Earnings and Revenue History